Labajo, Erbien G.

HRN: 23-60-66  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/27/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
08/27/2023
09/03/2023
ORAL
3.5ml
TID
Amoebiasis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: